These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11768727)

  • 41. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of L- and N-Type Ca Channel Blocker Cilnidipine on Changes in Heart Rate and QT Interval During Dialysis.
    Iida T; Morimoto S; Amari Y; Ando T; Ichihara A
    Kidney Blood Press Res; 2017; 42(5):933-941. PubMed ID: 29166643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats.
    Takatsu M; Hattori T; Murase T; Ohtake M; Kato M; Nashima K; Nakashima C; Takahashi K; Ito H; Niinuma K; Aritomi S; Murohara T; Nagata K
    J Hypertens; 2012 Sep; 30(9):1845-55. PubMed ID: 22796710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome.
    Konda T; Enomoto A; Matsushita J; Takahara A; Moriyama T
    Nephron Physiol; 2005; 101(1):p1-13. PubMed ID: 15886499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of L/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats.
    Konda T; Enomoto A; Takahara A; Yamamoto H
    Biol Pharm Bull; 2006 May; 29(5):933-7. PubMed ID: 16651722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of a long-acting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlodipine) on ventricular ectopic beats in older hypertensive patients.
    Eguchi K; Kario K; Shimada K
    Hypertens Res; 2002 May; 25(3):329-33. PubMed ID: 12135309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.
    Konda T; Enomoto A; Aritomi S; Niinuma K; Koganei H; Ogawa T; Nitta K
    Am J Nephrol; 2009; 30(2):155-61. PubMed ID: 19325231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats.
    Hosono M; Fujii S; Hiruma T; Watanabe K; Hayashi Y; Ohnishi H; Takata Y; Kato H
    Jpn J Pharmacol; 1995 Oct; 69(2):127-34. PubMed ID: 8569049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients.
    Kitahara Y; Saito F; Akao M; Fujita H; Takahashi A; Taguchi H; Hino T; Otsuka Y; Kushiro T; Kanmatsuse K
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):68-73. PubMed ID: 14668570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension.
    Binggeli C; Corti R; Sudano I; Luscher TF; Noll G
    Hypertension; 2002 Apr; 39(4):892-6. PubMed ID: 11967245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histological protection by cilnidipine, a dual L/N-type Ca(2+) channel blocker, against neurotoxicity induced by ischemia-reperfusion in rat retina.
    Sakamoto K; Kawakami T; Shimada M; Yamaguchi A; Kuwagata M; Saito M; Nakahara T; Ishii K
    Exp Eye Res; 2009 May; 88(5):974-82. PubMed ID: 19166832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Novel actions of calcium channel blockers].
    Kumagai H; Onami T; Takimoto C; Iigaya K; Hayashi K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():311-7. PubMed ID: 16983770
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: a literature review comparing amlodipine and nifedipine GITS.
    Toal CB; Meredith PA; Elliott HL
    Blood Press; 2012 Jul; 21 Suppl 1(Suppl 1):3-10. PubMed ID: 22762301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of cilnidipine on insulin sensitivity in patients with essential hypertension.
    Yagi S; Goto S; Yamamoto T; Kurihara S; Katayama S
    Hypertens Res; 2003 May; 26(5):383-7. PubMed ID: 12887129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-proteinuric effect of an N-type calcium channel blocker, cilnidipine.
    Tsuchihashi T; Ueno M; Tominaga M; Kajioka T; Onaka U; Eto K; Goto K
    Clin Exp Hypertens; 2005 Nov; 27(8):583-91. PubMed ID: 16303635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and rationale of the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.
    Matsuoka H; Ando K; Ueshima K; Babazono T; Kario K; Tanaka S; Nakao K; Fujita T;
    Clin Exp Hypertens; 2011; 33(7):455-62. PubMed ID: 21649534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension.
    Inomata J; Murai H; Kaneko S; Hamaoka T; Ikeda T; Kobayashi D; Usui S; Furusho H; Sugiyama Y; Takata S; Takamura M
    J Hypertens; 2014 Sep; 32(9):1898-904. PubMed ID: 24979307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus. Analysis after switching from cilnidipine to benidipine.
    Seino H; Miyaguchi S; Yamazaki T; Ota S; Yabe R; Suzuki S
    Arzneimittelforschung; 2007; 57(8):526-31. PubMed ID: 17915639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22
    Chopra HK; Wander GS; Ponde CK; Nanda NC; Khullar D; Venugopal K; Ray S; Nair T; Rana DS; Kher V; Sawhney J; Kasliwal RR; Abdullakutty J; Chakraborty R; Chandra P; Bansal S; Kumar V; Pancholia AK; Kapoor A; Prakash S; Saxena A; Rastogi V; Sharma V; Arora YK; Dasbiswas A; Bhargava M; Jaswal A; Bhargava K; Bhatia M; Omar AK; Khanna NN; Passey R; Bhalla D; Vijayalakshmi IB; Bhalla AK; Moorthy A; Isser HS; Mishra SS; Routray S; Tandon V; Sinha A; Bansal M; Jain P; Hotchandani R; Jain D; Katyal VK; Gulati S; Tandon R; Jaggi S; Sehgal B; Gupta V; Mehrotra R; Krishnamani NC; Pathak SN; Yadav MS; Chawla R; Shastry NR; Chatterjee N; Samajdar SS; Pal J; Tiwaskar M
    J Assoc Physicians India; 2024 Jan; 72(1):88-95. PubMed ID: 38736080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.